NCT00144638

Brief Summary

Procalcitonin, a marker of infection has often been compared to clinical pictures as for instance "clinical sepsis". This has given som problems in the interpretation of these studies, because of the lack of good Gold Standards for "clinical sepsis. We have decided to investigate the development from day to day of Procalcitonin in the blood of intensive care patients, compared to the mortality. Hypothesis: Procalcitonin increase after reaching a certain level predicts mortality in the Intensive Care Unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2002

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2002

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2003

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 1, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 5, 2005

Completed
Last Updated

September 5, 2005

Status Verified

February 1, 2005

First QC Date

September 1, 2005

Last Update Submit

September 1, 2005

Conditions

Sepsis - to Reduce Mortality in the Intensive Care Unit

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

  • Recent (\< 3 months) liver transplantation
  • Expected admission \< 24 h

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. 4131, Rigshospitalet, Cph University Hosp., DK

Copenhagen, DK-2100, Denmark

Location

Study Officials

  • Lars Heslet, MD, MD.Sc.

    Dept. 4131, Rigshospitalet, Blegdamsvej 9, DK-2100

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 1, 2005

First Posted

September 5, 2005

Study Start

January 1, 2002

Study Completion

January 1, 2003

Last Updated

September 5, 2005

Record last verified: 2005-02

Locations

DK(1)